<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01272622</url>
  </required_header>
  <id_info>
    <org_study_id>DKSR 463</org_study_id>
    <nct_id>NCT01272622</nct_id>
  </id_info>
  <brief_title>Prospective Study of Children and Adolescents With Craniopharyngioma</brief_title>
  <official_title>KRANIOPHARYNGEOM 2007 - Multicenter Prospective Study of Children and Adolescents With Craniopharyngioma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Oldenburg gGmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arbeitsgemeinschaft Pädiatrische Endokrinologie (APE)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deutsche Gesellschaft für Endokrinologie (DGE)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arbeitsgemeinschaft Pädiatrische Radioonkologie (APRO)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deutsche Gesellschafr für Radioonkologie (DEGRO)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deutsche Kinderkrebsstiftung</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>International Society of Paediatric Oncology (SIOP)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Klinikum Oldenburg gGmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present investigation is a prospective, multicenter study evaluating craniopharyngioma
      patients' prognoses following the various currently-practiced therapeutic strategies.Primary
      goals of the study are to establish quality standards and compare the various therapy
      strategies with respect to their effectiveness and impact on the quality of life of treated
      patients. A stratified randomization of two treatment arms will be conducted with respect to
      timing of postoperative irradiation for the subgroup of patients ≥5 years of age whose tumors
      are incompletely resected. The researchers will investigate whether an immediate,
      postoperative irradiation is superior to progression-contingent irradiation based on
      alterations to quality of life (PEDQOL) from the time randomization is initiated (3rd month
      post op) to 3 years after randomization. Progression-free survival and overall survival will
      be examined as closely-related subgoals.Postoperative data will be evaluated via a
      surveillance study for all complete resection patients as well as for those patients under 5
      years of age regardless of their resection grade.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 years after diagnosis</time_frame>
    <description>•Randomized investigation of children (≥ 5 years of age) and adolescent QoL changes (main goal assessment) following incomplete craniopharyngioma resections at primary diagnosis per QoL endpoint scores (PEDQOL &quot;physical functions&quot; domain) measured from 3rd month after surgery for 3 years after randomization; and the progression-free and total survival rates (subgoal assessments) relative to how these rates relate to postoperative irradiation timing (immediate postsurgery irradiation versus wait-and-see approach + progression-contingent irradiation of residual tumor).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of Progression or relapse</measure>
    <time_frame>3 years after surgery</time_frame>
    <description>Compilation of applied therapy strategies for craniopharyngiomas in children and adolescents using data capture conforming to SIOP brain tumor groups
Evaluation of patients' remission status following the various therapy strategies/modalities for craniopharyngiomas using data detection consistent with SIOP brain tumor groups
Evaluation of the health status (ophthalmologic, neuropsychologic and endocrine conditions) and health-related QoL of children and adolescents following treatment of craniopharyngiomas using data capture conforming to SIOP brain tumor groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Craniopharyngioma</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Arm I</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Children and adolescents &gt;= 18 years of age new diagnosed with craniopharyngioma
&gt;= 5 years of age and with incomplete resected tumor =&gt; randomized in two arms: immediate irradiation after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>incomplete resection, wait and watch, MRI-controls every 3 months, and irradiation at the time of progression of residual tumor</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiation</intervention_name>
    <description>Immediate irradiation after incomplete resection (fractionated, percutaneous irradiation, 54 gy)</description>
    <arm_group_label>Arm I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>wait and watch</intervention_name>
    <description>wait ans watch, MRI controls, irradiation at the time of progression of residual tumor</description>
    <arm_group_label>Arm II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosed with craniopharyngioma for the first time

          2. Age at diagnosis 18 years or less of age

          3. Agreement from patient's parents or legal guardian as well as the patient

        Criteria for inclusion in randomization study

          1. Histological diagnosis of craniopharyngioma

          2. Age at diagnosis 18 years or less of age

          3. Age at primary surgery over 5 years of age

          4. Incomplete primary resection

          5. Reference radiological confirmation of an incomplete resection

          6. Agreement from patient's parents or legal guardian as well as the patient

        Exclusion Criteria:

        Age at diagnosis over 18 years of age No QoL measurement for randomization (3 months after
        surgery).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hermann L Müller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum Oldenburg gGmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hermann L Mueller, MD</last_name>
    <phone>+49 441 403</phone>
    <phone_ext>2013</phone_ext>
    <email>mueller.hermann@klinikum-oldenburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ursel Gebhardt, phD</last_name>
    <phone>+49 403 441</phone>
    <phone_ext>2072</phone_ext>
    <email>kikra.doku@klinikum-oldenburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum Oldenburg</name>
      <address>
        <city>Oldenburg</city>
        <state>Niedersachsen</state>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hermann L Mueller, MD</last_name>
      <phone>+49 441 403</phone>
      <phone_ext>2013</phone_ext>
      <email>mueller.hermann@klinikum-oldenburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Ursel Gebhardt, phD</last_name>
      <phone>+49 441 403</phone>
      <phone_ext>2072</phone_ext>
      <email>kikra.doku@klinikum-oldenburg.de</email>
    </contact_backup>
    <investigator>
      <last_name>Hermann L Mueller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2011</study_first_submitted>
  <study_first_submitted_qc>January 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2011</study_first_posted>
  <last_update_submitted>September 15, 2016</last_update_submitted>
  <last_update_submitted_qc>September 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Oldenburg gGmbH</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Hermann Mueller</investigator_full_name>
    <investigator_title>Professor MD</investigator_title>
  </responsible_party>
  <keyword>Quality of life</keyword>
  <keyword>Endocrinology</keyword>
  <keyword>Oncology</keyword>
  <keyword>Hypothalamus</keyword>
  <keyword>Irradiation</keyword>
  <keyword>Neurosurgery</keyword>
  <keyword>Pediatric Brain tumors</keyword>
  <keyword>Randomized trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Craniopharyngioma</mesh_term>
    <mesh_term>Adamantinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

